Citation

Strober BE, Langley RGB, Menter A, Magid M, Porter B, Fox T, Safi J, Papavassilis C. Br. J. Dermatol. 2018; 178(2): e105-e107.

Copyright

(Copyright © 2018, John Wiley and Sons)

DOI

10.1111/bjd.16051

PMID

28991372

Abstract

[Abstract unavailable]

Language: en

Keywords

Humans; Risk Factors; Randomized Controlled Trials as Topic; Suicidal Ideation; Double-Blind Method; Anxiety Disorders; Psoriasis; Depressive Disorder; Dermatologic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clinical Trials, Phase III as Topic; Clinical Trials, Phase II as Topic